These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 35848896

  • 1. Circulating cancer-associated extracellular vesicles as early detection and recurrence biomarkers for pancreatic cancer.
    Yoshioka Y, Shimomura M, Saito K, Ishii H, Doki Y, Eguchi H, Nakatsura T, Itoi T, Kuroda M, Mori M, Ochiya T.
    Cancer Sci; 2022 Oct; 113(10):3498-3509. PubMed ID: 35848896
    [Abstract] [Full Text] [Related]

  • 2. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
    Nesteruk K, Levink IJM, de Vries E, Visser IJ, Peppelenbosch MP, Cahen DL, Fuhler GM, Bruno MJ.
    Pancreatology; 2022 Jun; 22(5):626-635. PubMed ID: 35613957
    [Abstract] [Full Text] [Related]

  • 3. miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma.
    Xu X, Bhandari K, Xu C, Morris K, Ding WQ.
    Int J Mol Sci; 2023 Apr 13; 24(8):. PubMed ID: 37108374
    [Abstract] [Full Text] [Related]

  • 4. CD63-positive extracellular vesicles are potential diagnostic biomarkers of pancreatic ductal adenocarcinoma.
    Odaka H, Hiemori K, Shimoda A, Akiyoshi K, Tateno H.
    BMC Gastroenterol; 2022 Mar 28; 22(1):153. PubMed ID: 35350978
    [Abstract] [Full Text] [Related]

  • 5. Extracellular vesicles from pancreatic ductal adenocarcinoma endoscopic ultrasound-fine needle aspiration samples contain a protein barcode.
    Inoue H, Eguchi A, Kobayashi Y, Usugi E, Yamada R, Tsuboi J, Akuta T, Horiki N, Iwasa M, Takei Y.
    J Hepatobiliary Pancreat Sci; 2022 Mar 28; 29(3):394-403. PubMed ID: 34555251
    [Abstract] [Full Text] [Related]

  • 6. Integrin α6A (ITGA6A)-type Splice Variant in Extracellular Vesicles Has a Potential as a Novel Marker of the Early Recurrence of Pancreatic Cancer.
    Asada T, Nakahata S, Fauzi YR, Ichikawa T, Inoue K, Shibata N, Fujii Y, Imamura N, Hiyoshi M, Nanashima A, Morishita K.
    Anticancer Res; 2022 Apr 28; 42(4):1763-1775. PubMed ID: 35346995
    [Abstract] [Full Text] [Related]

  • 7. Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Guo S, Qin H, Liu K, Wang H, Bai S, Liu S, Shao Z, Zhang Y, Song B, Xu X, Shen J, Zeng P, Shi X, Chen H, Gao S, Xu J, Pan Y, Xiong L, Li F, Zhang D, Jiao X, Jin G.
    Clin Transl Med; 2021 Sep 28; 11(9):e520. PubMed ID: 34586739
    [Abstract] [Full Text] [Related]

  • 8. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma.
    Han Y, Drobisch P, Krüger A, William D, Grützmann K, Böthig L, Polster H, Seifert L, Seifert AM, Distler M, Pecqueux M, Riediger C, Plodeck V, Nebelung H, Weber GF, Pilarsky C, Kahlert U, Hinz U, Roth S, Hackert T, Weitz J, Wong FC, Kahlert C.
    J Hematol Oncol; 2023 Feb 03; 16(1):7. PubMed ID: 36737824
    [Abstract] [Full Text] [Related]

  • 9. Size and Concentration of Extracellular Vesicles in Pancreatic Juice From Patients With Pancreatic Ductal Adenocarcinoma.
    Nesteruk K, Levink IJM, Dits NFJ, Cahen DL, Peppelenbosch MP, Bruno MJ, Fuhler GM.
    Clin Transl Gastroenterol; 2022 Feb 18; 13(3):e00465. PubMed ID: 35363220
    [Abstract] [Full Text] [Related]

  • 10. Small RNA sequencing analysis of peptide-affinity isolated plasma extracellular vesicles distinguishes pancreatic cancer patients from non-affected individuals.
    Roy JW, Wajnberg G, Ouellette A, Boucher JE, Lacroix J, Chacko S, Ghosh A, Ouellette RJ, Lewis SM.
    Sci Rep; 2023 Jun 07; 13(1):9251. PubMed ID: 37286718
    [Abstract] [Full Text] [Related]

  • 11. Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA.
    Wu H, Guo S, Liu X, Li Y, Su Z, He Q, Liu X, Zhang Z, Yu L, Shi X, Gao S, Wang H, Pan Y, Ma C, Liu R, Dai M, Jin G, Liang Z.
    BMC Med; 2022 Nov 25; 20(1):458. PubMed ID: 36434648
    [Abstract] [Full Text] [Related]

  • 12. Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma.
    Liu DSK, Puik JR, Patel BY, Venø MT, Vahabi M, Prado MM, Webber JP, Rees E, Upton FM, Bennett K, Blaker C, Immordino B, Comandatore A, Morelli L, Sivakumar S, Swijnenburg RJ, Besselink MG, Jiao LR, Kazemier G, Giovannetti E, Krell J, Frampton AE.
    J Exp Clin Cancer Res; 2024 Jul 08; 43(1):189. PubMed ID: 38978141
    [Abstract] [Full Text] [Related]

  • 13. Liquid Biopsy for Pancreatic Cancer by Serum Extracellular Vesicle-Encapsulated Long Noncoding RNA HEVEPA.
    Takahashi K, Inuzuka T, Shimizu Y, Sawamoto K, Taniue K, Ono Y, Asai F, Koyama K, Sato H, Kawabata H, Iwamoto H, Yamakita K, Kitano Y, Teramoto T, Fujiya M, Fujii S, Mizukami Y, Okumura T.
    Pancreas; 2024 May 01; 53(5):e395-e404. PubMed ID: 38416857
    [Abstract] [Full Text] [Related]

  • 14. Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer.
    Takahashi K, Ota Y, Kogure T, Suzuki Y, Iwamoto H, Yamakita K, Kitano Y, Fujii S, Haneda M, Patel T, Ota T.
    Cancer Sci; 2020 Jan 01; 111(1):98-111. PubMed ID: 31715081
    [Abstract] [Full Text] [Related]

  • 15. Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics.
    Guerreiro EM, Øvstebø R, Thiede B, Costea DE, Søland TM, Kanli Galtung H.
    PLoS One; 2020 Jan 01; 15(9):e0238591. PubMed ID: 32886718
    [Abstract] [Full Text] [Related]

  • 16. Proteomic analysis distinguishes extracellular vesicles produced by cancerous versus healthy pancreatic organoids.
    Buenafe AC, Dorrell C, Reddy AP, Klimek J, Marks DL.
    Sci Rep; 2022 Mar 03; 12(1):3556. PubMed ID: 35241737
    [Abstract] [Full Text] [Related]

  • 17. A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma.
    Xu C, Jun E, Okugawa Y, Toiyama Y, Borazanci E, Bolton J, Taketomi A, Kim SC, Shang D, Von Hoff D, Zhang G, Goel A.
    Gastroenterology; 2024 Jan 03; 166(1):178-190.e16. PubMed ID: 37839499
    [Abstract] [Full Text] [Related]

  • 18. Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technology.
    Zeöld A, Sándor GO, Kiss A, Soós AÁ, Tölgyes T, Bursics A, Szűcs Á, Harsányi L, Kittel Á, Gézsi A, Buzás EI, Wiener Z.
    Cell Mol Life Sci; 2021 Mar 03; 78(6):3005-3020. PubMed ID: 33237353
    [Abstract] [Full Text] [Related]

  • 19. Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project.
    Bardol T, Dujon AM, Taly V, Dunyach-Remy C, Lavigne JP, Costa-Silva B, Kurma K, Eslami-S Z, Cayrefourcq L, Canivet C, Muscari F, Bournet B, Alix-Panabières C.
    BMC Cancer; 2024 Jun 10; 24(1):709. PubMed ID: 38853244
    [Abstract] [Full Text] [Related]

  • 20. IgG+ Extracellular Vesicles Measure Therapeutic Response in Advanced Pancreatic Cancer.
    Couto N, Elzanowska J, Maia J, Batista S, Pereira CE, Beck HC, Carvalho AS, Strano Moraes MC, Carvalho C, Oliveira M, Matthiesen R, Costa-Silva B.
    Cells; 2022 Sep 08; 11(18):. PubMed ID: 36139375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.